| Title |
<i>Aloe vera</i> for prevention and treatment of infusion phlebitis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2014
|
| DOI | 10.1002/14651858.cd009162.pub2 |
| Pubmed ID | |
| Authors |
Guo Hua Zheng, Liu Yang, Hai Ying Chen, Jian Feng Chu, Lijuan Mei |
| Abstract |
Up to 80% of hospitalised patients receive intravenous therapy at some point during their admission. About 20% to 70% of patients receiving intravenous therapy develop phlebitis. Infusion phlebitis has become one of the most common complications in patients with intravenous therapy. However, the effects of routine treatments such as external application of 75% alcohol or 50% to 75% magnesium sulphate (MgSO4) are unsatisfactory. Therefore, there is an urgent need to develop new methods to prevent and alleviate infusion phlebitis. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 60% |
| Austria | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Science communicators (journalists, bloggers, editors) | 1 | 20% |
| Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 263 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Ireland | 1 | <1% |
| Canada | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 259 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 43 | 16% |
| Student > Master | 37 | 14% |
| Researcher | 22 | 8% |
| Student > Ph. D. Student | 20 | 8% |
| Other | 18 | 7% |
| Other | 44 | 17% |
| Unknown | 79 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 74 | 28% |
| Nursing and Health Professions | 47 | 18% |
| Psychology | 13 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 3% |
| Biochemistry, Genetics and Molecular Biology | 7 | 3% |
| Other | 26 | 10% |
| Unknown | 87 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2023.
All research outputs
#2,359,037
of 25,870,940 outputs
Outputs from Cochrane database of systematic reviews
#4,756
of 13,151 outputs
Outputs of similar age
#22,628
of 243,136 outputs
Outputs of similar age from Cochrane database of systematic reviews
#91
of 236 outputs
Altmetric has tracked 25,870,940 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,151 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,136 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.